Curtis Oltmans
Overview
Curtis Oltmans received an average of $2M in total compensation, including $294K in salary, at Fulcrum Therapeutics from 2020 to 2023. Curtis Oltmans also received $4M at Array BioPharma in 2018.
Source: SEC filings on April 19, 2024, April 29, 2021, and September 14, 2018.
Related executives
We found 20 more executives who work or worked at Fulcrum Therapeutics and Array BioPharma.
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
Robert Gould
Fulcrum Therapeutics
Chief Executive Officer
Owen Wallace
Fulcrum Therapeutics
Chief Scientific Officer
Ron Squarer
Array BioPharma
Chief Executive Officer
Andrew Robbins
Array BioPharma